Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855627) titled 'Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements' on Sept. 29.
Study Type: Observational
Primary Sponsor: M.D. Anderson Cancer Center
Condition:
Lymphedema
Inflammatory Breast Cancer (IBC)
Preoperative
Bioimpedance Measurement
Intervention:
Drug: Neoadjuvant therapy
Recruitment Status: Recruiting
Date of First Enrollment: September 16, 2026
Target Sample Size: 150
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07855627
Published by HT Digital Content Services with permission from Health Daily D...